NASDAQ

Outlook Therapeutics, Inc. (OTLK)

♥ 673 Thanks from members

Live price chart, market sentiment, and community perspectives for Outlook Therapeutics, Inc. (NASDAQ: OTLK).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiopharmaceuticalsFounder: Outlook Therapeutics FoundersLeadership: Russell Trenary (CEO)Leadership: Cynthia McCarthy (CFO)Holder: GMS CapitalHolder: Institutional InvestorsHolder: InsidersLYTENAVA (ONS-5010)#Outlook Therapeutics#OTLK stock#Ophthalmic Biologics#Bevacizumab#NASDAQ OTLK